© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
Large-Scale Study Challenges Previous Research on Menopause and Brain Structure
November 11, 2025
TMS 2025: Katrina Wugalter, MA, discusses research showing that age—not menopause stage—drives brain volume decline, and how lifestyle factors can help preserve brain health in midlife women.
Mayo Clinic Researcher on Why Menopause Stage Matters in Metabolic Research
November 11, 2025
TMS 2025: Regina Castaneda, MD, explains why reproductive stage is a critical variable in obesity and metabolic research.
Tapinarof Cream 1%, Shows Early and Durable Response in Children With Atopic Dermatitis
November 11, 2025
ACAAI 2025. Phase 3 data show tapinarof cream provides early, sustained improvement and good tolerability in children aged ≥2 years with atopic dermatitis.
Menopause Treatment in Real-World Practice: Ob/Gyn Anna Christine Cochrane, MD Highlights New Research
November 11, 2025
Cochrane shares her own research findings on how clinician specialty shapes menopause care and highlights gaps in hormone therapy prescribing.
Vitamin D Dosing Tailored to Optimal Levels Reduced Risk of Recurrent MI by More Than Half
November 11, 2025
The TARGET-D trial found targeted vitamin D dosing post-MI didn’t lower MACE but reduced recurrent MI risk, supporting individualized serum-level management.
Cushing Syndrome: Clinical Features, Screening Tests, and When to Refer
November 11, 2025
Recognize Cushing syndrome in primary care: key clinical clusters, first-line screening tests (DST, salivary cortisol, UFC), and when to refer to endocrinology.
Sublingual Epinephrine Film Well Tolerated in Children, Matches Efficacy Seen in Adults
November 10, 2025
Sublingual epinephrine film matches adult PK/PD in kids aged 7-17 with a history of allergic reactions and high risk for serious allergic reactions, incluing anaphylaxis.
FDA to Remove “Black Box” Warnings from Hormone Replacement Therapy Products
November 10, 2025
Regulatory update aims to align labeling with current evidence on menopausal hormone therapy safety and benefits
Investigational Oral PCSK-9 Inhibitor Reduces LDL-C by 60% in Late Stage HeFH Trial
November 10, 2025
Merck's oral PCSK9 inhibitor enlicitide demonstrated antibody-like LDL-C lowering in adutls with HeFH with safety profile similar to placebo in phase 3 trial.
Treg-Targeting Rezpegaldesleukin Demonstrates Dual Benefit for Asthma and Atopic Dermatitis
November 10, 2025
Phase 2b findings show rezpegaldesleukin reduced ACQ-5 scores and improved key AD endpoints in participants with comorbid asthma.